Emergent Product Development UK Limited

Microscience Limited

Martin John Glenton Hughes

Gordon Dougan

Robert Graham Feldman

Joseph David Santangelo

Paul Howard Everest

Jonathan Douglas Lane

Joanne Christine Moore

Richard James Dobson

Rebecca Kerry Wilson

Caroline Joanne Henwood

A protein from Group Bis shown to be an outer surface protein and is a useful target for antimicrobial therapy.

Genes and proteins, and their use

According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines to immunize a patient against microbial infection.

According to the present invention, a series of genes are identified in Group B, the products of which may be located on the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines for the immunization of a patient against microbial infection.

NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use

According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be associated with the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vacaccines to immunize a patient against microbial infection.

Growing community of inventors

Berkshire, United Kingdom

Martin John Glenton Hughes